Current Health will work with the Biomedical Advanced Research and Development Authority (BARDA) in an effort to support caregivers in monitoring the status of COVID-19 patients, detect deterioration in their health before it occurs, and predict the likely severity of their disease in advance. The work will utilize Current Health’s remote-monitoring platform to assist in management and treatment of patients, and to develop a digital biomarker-based algorithm that can alert to the need for hospitalization and ICU-level care.
Outsourcing-Pharma (OSP) discussed the initiative with Stewart Whiting (SW), chief technical officer of Current Health.
OSP: What are some of the benefits of advanced monitoring of COVID-19 patients?
SW: By using advanced remote patient monitoring (RPM) solutions, clinicians can continuously monitor key vital signs, such as respiration rate and oxygen saturation of COVID-19 patients, allowing them to capture the broadest picture of human health and the patient’s symptoms.
This advanced monitoring ensures that COVID-19 patients are continuously observed and providers are proactively alerted when any issues are detected, enabling earlier intervention and better outcomes for COVID-19 patients.
For instance, if a patient’s movement level is low, their oxygen levels drop or their core temperature shows a fever, an alert would immediately be sent to care staff who could analyze the symptoms. Staff can then either intervene through a virtual visit, phone call or text message, recommend the patient comes to the hospital or clinic, or send an ambulance if the patient becomes critical.
"current" - Google News
October 22, 2020 at 08:59PM
https://ift.tt/3mcZBsB
BARDA enlists Current Health in COVID-19 monitoring - OutSourcing-Pharma.com
"current" - Google News
https://ift.tt/3b2HZto
https://ift.tt/3c3RoCk
Bagikan Berita Ini
0 Response to "BARDA enlists Current Health in COVID-19 monitoring - OutSourcing-Pharma.com"
Post a Comment